Navigation Links
Human Genome Sciences Submits Biologics License Application to FDA for ABthrax(TM)
Date:5/21/2009

- First-in-class treatment for inhalation anthrax -

ROCKVILLE, Md., May 21 /PRNewswire-FirstCall/ -- Human Genome Sciences, Inc. (Nasdaq: HGSI) today announced that it has submitted a Biologics License Application (BLA) to the U.S. Food and Drug Administration (FDA) for its human monoclonal antibody drug ABthrax(TM) (raxibacumab) for the treatment of inhalation anthrax.

(Logo: http://www.newscom.com/cgi-bin/prnh/20080416/HGSLOGO )

The BLA submission includes the results of two randomized placebo-controlled studies conducted in rabbits and monkeys to evaluate the efficacy of raxibacumab. These studies showed a survival benefit in two relevant animal species, which is the requirement for establishing the efficacy of new drugs used to counter bioterrorism. The submission also includes the results of safety studies of raxibacumab conducted in healthy human volunteers.

"Based on the results of our efficacy and safety studies, we believe raxibacumab has the potential to be an important new treatment for inhalation anthrax," said Sally D. Bolmer, Ph.D., R.A.C, Senior Vice President, Development and Regulatory Affairs, HGS. "In addition, the raxibacumab BLA is the first HGS has submitted, so it represents a significant milestone for our Company."

Raxibacumab is a first-in-class treatment for anthrax, and is being developed under a contract entered into in 2006 with the Biomedical Advanced Research and Development Authority (BARDA) of the Office of the Assistant Secretary for Preparedness and Response (ASPR), U.S. Department of Health and Human Services (HHS).

In the first quarter of 2009, under t
'/>"/>

SOURCE Human Genome Sciences, Inc.
Copyright©2009 PR Newswire.
All rights reserved

0

GOOD

Page: 1 2 3 4

Related medicine technology :

1. Video: New Research Discovers Independent Brain Networks Control Human Walking
2. Lpath Demonstrates Strong Safety Profile of Lead Drug Candidate, Sphingomab(TM), in Non-Human Primates
3. Enrollment Begins on Human PK Study for Medidur(TM) FA
4. Human Genome Sciences Completes Enrollment of First Phase 3 Albuferon(R) Trial Ahead of Schedule
5. Study Confirms Limited Human-To-Human Spread of Avian-Flu Virus in Indonesia in 2006
6. Lpath Demonstrates Preclinical Efficacy of Lpathomab(TM) and Initiates Humanization Process
7. Peregrine Researchers Report Data Showing Bavituximabs Potential to Shrink Human Prostate Tumors in Model of Relapsed Disease
8. Dr. Roger Kenneth Hershline PhD MD, CEO of Global Humanceuticals, Inc. Donates New HIV Drug
9. Study Shows Plasma-Derived Human Thrombin Equivalent to Bovine Thrombin in Achieving Hemostasis in Surgery
10. Tengion Launches Second Phase 2 Clinical Trial of Regenerated Human Organ
11. Flexible Medical Systems Raises $1.2M Seed Investment for Initial Human Trials

Post Your Comments:
*Name:
*Comment:
*Email:
(Date:11/25/2009)...25/PRNewswire-FirstCall/--HeskaCorporation(HSKA);(...specialtyproductstotheveterinaryindustry,announced...hesupplyofbloodgasproductsandaffiliatedconsumables...wscom.com/cgi-bin/prnh/20000622/HESKALOGO ) ,, ...efieldofadvancedpoint-of-carediagnostics,"commente...
(Date:11/25/2009)...25/PRNewswire-FirstCall/--Pharmasset,Inc.(Nasdaq: ...dtodiscovering,developingandcommercializingnoveldr...forthefiscalyearendedSeptember30,2009.AtSeptember3...entsandshortterminvestments. ,, PipelineUpdate...rial ,, InlateNovember2009,anindependentDataM...
(Date:11/25/2009)...tzerland,Nov.25/PRNewswire/-- FromNovember16-18,Ph...tions,presentedthesecondeditionoftheHearingCarefor...erpopulation.Theconferencebroughttogetherleadingex...han250clinicianswhoworkeverydaywitholderpeoplewith...scussthelatestresearchandtrendsinhearingcareforold...
Breaking Medicine Technology:Heska Announces Supply Agreement With Roche Diagnostics 2Heska Announces Supply Agreement With Roche Diagnostics 3Pharmasset Reports Fiscal Year End 2009 Financial Results 2Pharmasset Reports Fiscal Year End 2009 Financial Results 3Pharmasset Reports Fiscal Year End 2009 Financial Results 4Pharmasset Reports Fiscal Year End 2009 Financial Results 5Pharmasset Reports Fiscal Year End 2009 Financial Results 6Pharmasset Reports Fiscal Year End 2009 Financial Results 7Pharmasset Reports Fiscal Year End 2009 Financial Results 8Phonak Successfully Hosts Hearing Care for Adults 2009 Conference 2Phonak Successfully Hosts Hearing Care for Adults 2009 Conference 3QHR and Valley Health Amicably Part Ways 48030 1QHR and Valley Health Amicably Part Ways 48030 2New Provisional Restorations In Dentistry DVD by Paul R Chalifoux DDS 48026 1New Provisional Restorations In Dentistry DVD by Paul R Chalifoux DDS 48026 2Angelica Corporation Raises Bar Again for Increased Patient Safety 48022 1Angelica Corporation Raises Bar Again for Increased Patient Safety 48022 2
...Panelists to Discuss Trends, Trials, and Innovatio... Conferences, CLEVELAND, Sept. 25 Cleveland Clin... on medical innovation and emerging trends,in card...riving the development of new therapies, treat... The 5th annual Cleveland Clinic Medical Inno...
...rena Pharmaceuticals,Inc. (Nasdaq: ARNA ) today a...se 2 clinical trial of APD125 in patients with chr...candidate discovered by Arena that is being,evalua...aining sleep after,initial sleep onset. When compa...ienced statistically significant improvements in m...
Other Medicine Technology:Cleveland Clinic Summits to Focus on Cardiovascular Medical Innovation 2Cleveland Clinic Summits to Focus on Cardiovascular Medical Innovation 3Arena Pharmaceuticals Announces Positive Phase 2 Clinical Trial Results of APD125 for the Treatment of Insomnia 2Arena Pharmaceuticals Announces Positive Phase 2 Clinical Trial Results of APD125 for the Treatment of Insomnia 3Arena Pharmaceuticals Announces Positive Phase 2 Clinical Trial Results of APD125 for the Treatment of Insomnia 4Arena Pharmaceuticals Announces Positive Phase 2 Clinical Trial Results of APD125 for the Treatment of Insomnia 5Arena Pharmaceuticals Announces Positive Phase 2 Clinical Trial Results of APD125 for the Treatment of Insomnia 6Arena Pharmaceuticals Announces Positive Phase 2 Clinical Trial Results of APD125 for the Treatment of Insomnia 7
(Date:11/25/2009)...swire/--TheAmericanAssociationforHomecareendorsest...hisdesignedtosubstantiallyimprovetoolsandresources...ucedbySen.GeorgeLeMieux(R-Fla.). ,, TheLeMieuxb...forHomecareoutlinedinits13-pointanti-fraudactionpl....Thoseprovisionsincludecallingforreal-timeauditsan...
(Date:11/25/2009)...d into the body on a carefully engineered, fingern...minate tumors in mammals, scientists report this w... . , The new approach, pioneered by bioengineers...stic disks impregnated with tumor-specific antigen...mmalian immune system to attack tumors. The new pa...
(Date:11/25/2009)...r in children with autism and related conditions c...medication combined with a structured training pro...earchers and their colleagues. , Published in t...ican Academy of Child and Adolescent Psychiatry , ...of Mental Health (NIMH) Research Units on Pediatri...
(Date:11/25/2009)...ed parts of speech colored perception of sounds ,... People can "hear" not only with their ears, but a...act, sensations on the skin designed to mimic cert...r sounds better, the Canadian scientists found. ,...ld use tactile information in this way," said Brya...
(Date:11/25/2009)...to include cost-effective, sustainable distance tr...essionals in developing world. , ...- Elluminate, Inc. , the leader in web, audio, v... 21st century teaching, learning, and collaboratio...ive was awarded iNACOL,s first-ever Outstanding a...
Breaking Medicine News(10 mins):Health News:American Association for Homecare Endorses New U.S. Senate Bill, the 'Prevent Health Care Fraud Act of 2009' 2Health News:Implant-based cancer vaccine is first to eliminate tumors in mice 2Health News:Parent training key to improved treatment of behavior problems in children with autism 2Health News:Your Skin Can Help Your Ears Listen 2Health News:Your Skin Can Help Your Ears Listen 3Health News:Elluminate's Fire and Ice Project Recognized as First-Ever iNACOL Award Winner for Outstanding and Most Innovative Online Learning Practice 2Health News:Elluminate's Fire and Ice Project Recognized as First-Ever iNACOL Award Winner for Outstanding and Most Innovative Online Learning Practice 3Health News:Elluminate's Fire and Ice Project Recognized as First-Ever iNACOL Award Winner for Outstanding and Most Innovative Online Learning Practice 4Health News:Elluminate's Fire and Ice Project Recognized as First-Ever iNACOL Award Winner for Outstanding and Most Innovative Online Learning Practice 5
...pment of cancer. Cells without this protein are us...ity would either kill a cell or keep it from growi...h a way that they are able to multiply creating tu...// E2F3 is part of a family of proteins called tra...
...se electrocardiograph tests should be the first-li... patients with chest pain. Even though negative fi...ings could not distinguish levels of risk. The res...inical or exercise electrocardiography.// They com...
...p to 10, authorities are not confident about the g...wn a far higher recovery rate than the rest of the... medical care provided to SARS patients. Even what...tist at the National Institute of Communicable Dis...
...everal countries are forecast to shrink in the sec...s, from Filipina maids to Indonesian laborers and ...ommerce in the region, sending home in excess of $...irectly improving standards of living// and boosti...
...dian clinics where staffs worried about catching t...vernment hospital. Private medical centre closed t...ARS infected patients. The patients include a brid...e quarantined later to check if they developed sym...
...ay probably be small if the trip isn't to Asia. Pu...ently known about the virus. However people can be... strong filters against viruses. There have even b... filters to screen out spores, bacteria and viruse...
Other Medicine News:
...atories is a national reference laboratory and a w...and development. ARUP offers an extensive test men...inical and anatomic pathology. Owned by the Univer...ore than half of the nation's university teaching ...
...atories is a national reference laboratory and a w...and development. ARUP offers an extensive test men...inical and anatomic pathology. Owned by the Univer...ore than half of the nation's university teaching ...
...atories is a national reference laboratory and a w...and development. ARUP offers an extensive test men...inical and anatomic pathology. Owned by the Univer...ore than half of the nation's university teaching ...
...atories is a national reference laboratory and a w...and development. ARUP offers an extensive test men...inical and anatomic pathology. Owned by the Univer...ore than half of the nation's university teaching ...
Medicine Products: